PDGFR inhibition in brain tumours--oft expectation fails where most it promises.
Raymond
Eric
E
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002648:Child; D005910:Glioma / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use*; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism; D018125:Receptors, Transforming Growth Factor beta / Q000378:metabolism*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D018125:Receptors, Transforming Growth Factor beta; D000068877:Imatinib Mesylate; D020797:Receptor, Platelet-Derived Growth Factor beta